Morgan Stanley’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35M | Buy |
466,149
+172,710
| +59% | +$11.1M | ﹤0.01% | 2563 |
|
|
2026
Q1 | $16.5M | Sell |
293,439
-269,510
| -48% | -$17.6M | ﹤0.01% | 3135 |
|
|
2025
Q4 | $45.1M | Buy |
562,949
+42,148
| +8% | +$2.83M | ﹤0.01% | 2176 |
|
|
2025
Q3 | $25.4M | Buy |
520,801
+22,752
| +5% | +$1.41M | ﹤0.01% | 2660 |
|
|
2025
Q2 | $37.2M | Buy |
498,049
+66,453
| +15% | +$4.4M | ﹤0.01% | 2188 |
|
|
2025
Q1 | $27.4M | Sell |
431,596
-65,976
| -13% | -$4.49M | ﹤0.01% | 2369 |
|
|
2024
Q4 | $38.9M | Buy |
497,572
+13,603
| +3% | +$1.09M | ﹤0.01% | 2072 |
|
|
2024
Q3 | $38.9M | Buy |
483,969
+66,963
| +16% | +$5.41M | ﹤0.01% | 2095 |
|
|
2024
Q2 | $34.5M | Buy |
417,006
+104,128
| +33% | +$9.16M | ﹤0.01% | 2108 |
|
|
2024
Q1 | $26.7M | Sell |
312,878
-127,005
| -29% | -$9.97M | ﹤0.01% | 2379 |
|
|
2023
Q4 | $37.6M | Sell |
439,883
-64,520
| -13% | -$5.58M | ﹤0.01% | 2018 |
|
|
2023
Q3 | $45.2M | Sell |
504,403
-11,729
| -2% | -$1.05M | ﹤0.01% | 1677 |
|
|
2023
Q2 | $43.9M | Buy |
516,132
+270,534
| +110% | +$22.9M | ﹤0.01% | 1687 |
|
|
2023
Q1 | $20.3M | Buy |
245,598
+4,706
| +2% | +$381K | ﹤0.01% | 2396 |
|
|
2022
Q4 | $18.9M | Sell |
240,892
-115,360
| -32% | -$9.27M | ﹤0.01% | 2396 |
|
|
2022
Q3 | $26.4M | Sell |
356,252
-12,853
| -3% | -$923K | ﹤0.01% | 1901 |
|
|
2022
Q2 | $24.1M | Sell |
369,105
-72,850
| -16% | -$4.31M | ﹤0.01% | 2077 |
|
|
2022
Q1 | $27.9M | Buy |
441,955
+3,115
| +0.7% | +$169K | ﹤0.01% | 1774 |
|
|
2021
Q4 | $23.3M | Buy |
438,840
+243,484
| +125% | +$14.8M | ﹤0.01% | 2001 |
|
|
2021
Q3 | $13.8M | Sell |
195,356
-492,997
| -72% | -$31.1M | ﹤0.01% | 2529 |
|
|
2021
Q2 | $45.9M | Buy |
688,353
+108,691
| +19% | +$7.69M | 0.01% | 1375 |
|
|
2021
Q1 | $64.3M | Sell |
579,662
-115,084
| -17% | -$14.2M | 0.01% | 1004 |
|
|
2020
Q4 | $82.5M | Sell |
694,746
-19,115
| -3% | -$2.06M | 0.01% | 809 |
|
|
2020
Q3 | $62.3M | Buy |
713,861
+271,109
| +61% | +$23.7M | 0.01% | 801 |
|
|
2020
Q2 | $39.7M | Buy |
442,752
+393,804
| +805% | +$39.8M | 0.01% | 954 |
|
|
2020
Q1 | $4.88M | Sell |
48,948
-351,760
| -88% | -$38.1M | ﹤0.01% | 2491 |
|
|
2019
Q4 | $46M | Buy |
400,708
+334,811
| +508% | +$40.5M | 0.01% | 991 |
|
|
2019
Q3 | $8.31M | Buy |
65,897
+13,604
| +26% | +$1.73M | ﹤0.01% | 2313 |
|
|
2019
Q2 | $6.29M | Sell |
52,293
-242,825
| -82% | -$23.9M | ﹤0.01% | 2685 |
|
|
2019
Q1 | $25.8M | Buy |
295,118
+124,028
| +72% | +$11.3M | 0.01% | 1265 |
|
|
2018
Q4 | $17.1M | Sell |
171,090
-97,454
| -36% | -$10.2M | 0.01% | 1597 |
|
|
2018
Q3 | $30.8M | Sell |
268,544
-103,518
| -28% | -$10.7M | 0.01% | 1300 |
|
|
2018
Q2 | $33.4M | Buy |
372,062
+209,439
| +129% | +$17.7M | 0.01% | 1168 |
|
|
2018
Q1 | $11.9M | Sell |
162,623
-34,231
| -17% | -$2.35M | ﹤0.01% | 2168 |
|
|
2017
Q4 | $11.4M | Buy |
196,854
+106,105
| +117% | +$5.59M | ﹤0.01% | 2273 |
|
|
2017
Q3 | $4.07M | Sell |
90,749
-220,705
| -71% | -$9.17M | ﹤0.01% | 3186 |
|
|
2017
Q2 | $12.3M | Buy |
311,454
+230,733
| +286% | +$9.48M | ﹤0.01% | 1973 |
|
|
2017
Q1 | $3.27M | Sell |
80,721
-82,484
| -51% | -$3.22M | ﹤0.01% | 3343 |
|
|
2016
Q4 | $6.56M | Buy |
163,205
+127,941
| +363% | +$4.82M | ﹤0.01% | 2710 |
|
|
2016
Q3 | $1.28M | Sell |
35,264
-28,490
| -45% | -$978K | ﹤0.01% | 3848 |
|
|
2016
Q2 | $1.85M | Buy |
63,754
+49,169
| +337% | +$1.49M | ﹤0.01% | 3491 |
|
|
2016
Q1 | $509K | Sell |
14,585
-90,632
| -86% | -$2.93M | ﹤0.01% | 4432 |
|
|
2015
Q4 | $3.39M | Sell |
105,217
-109,923
| -51% | -$3.57M | ﹤0.01% | 3039 |
|
|
2015
Q3 | $6.95M | Buy |
215,140
+167,838
| +355% | +$6.32M | ﹤0.01% | 2337 |
|
|
2015
Q2 | $1.96M | Buy |
47,302
+10,724
| +29% | +$452K | ﹤0.01% | 3652 |
|
|
2015
Q1 | $1.64M | Buy |
36,578
+17,775
| +95% | +$743K | ﹤0.01% | 3756 |
|
|
2014
Q4 | $704K | Sell |
18,803
-13,036
| -41% | -$478K | ﹤0.01% | 4434 |
|
|
2014
Q3 | $1.11M | Buy |
31,839
+4,372
| +16% | +$156K | ﹤0.01% | 3946 |
|
|
2014
Q2 | $969K | Sell |
27,467
-112,078
| -80% | -$3.74M | ﹤0.01% | 4078 |
|
|
2014
Q1 | $4.55M | Buy |
139,545
+121,216
| +661% | +$4.63M | ﹤0.01% | 2662 |
|
|
2013
Q4 | $773K | Sell |
18,329
-6,410
| -26% | -$264K | ﹤0.01% | 4124 |
|
|
2013
Q3 | $986K | Sell |
24,739
-41,021
| -62% | -$1.72M | ﹤0.01% | 3800 |
|
|
2013
Q2 | $2.72M | Buy |
+65,760
| New | +$2.66M | ﹤0.01% | 2892 |
|
Other funds holding HAE
AI
Morgan Stanley's HAE Position: Q2 2026 in Review
Morgan Stanley increased its Haemonetics (HAE) stake by 59% in Q2 2026, buying an estimated $11.1M and bringing the position to 466,149 shares worth $35M. The position accounts for ﹤0.01% of the portfolio, ranked #2563.
Morgan Stanley first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $82.5M in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Morgan Stanley held 466,149 shares of Haemonetics worth $35M as of Q2 2026.
- Morgan Stanley bought 172,710 Haemonetics shares in Q2 2026, an estimated $11.1M.
- Haemonetics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2563 holding.
- Morgan Stanley first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Haemonetics position peaked at $82.5M in Q4 2020.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.